Literature DB >> 26250349

Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis.

S Guerriero1, S Ajossa1, J A Minguez2, M Jurado2, V Mais1, G B Melis1, J L Alcazar2.   

Abstract

OBJECTIVE: To review the diagnostic accuracy of transvaginal ultrasound (TVS) in the preoperative detection of endometriosis in the uterosacral ligaments (USL), rectovaginal septum (RVS), vagina and bladder in patients with clinical suspicion of deep infiltrating endometriosis (DIE).
METHODS: An extensive search was performed in MEDLINE (PubMed) and EMBASE for studies published between January 1989 and December 2014. Studies were considered eligible if they reported on the use of TVS for the preoperative detection of endometriosis in the USL, RVS, vagina and bladder in women with clinical suspicion of DIE using the surgical data as a reference standard. Study quality was assessed using the PRISMA guidelines and QUADAS-2 tool.
RESULTS: Of the 801 citations identified, 11 studies (n = 1583) were considered eligible and were included in the meta-analysis. For detection of endometriosis in the USL, the overall pooled sensitivity and specificity of TVS were 53% (95%CI, 35-70%) and 93% (95%CI, 83-97%), respectively. The pretest probability of USL endometriosis was 54%, which increased to 90% when suspicion of endometriosis was present after TVS examination. For detection of endometriosis in the RVS, the overall pooled sensitivity and specificity were 49% (95%CI, 36-62%) and 98% (95%CI, 95-99%), respectively. The pretest probability of RVS endometriosis was 24%, which increased to 89% when suspicion of endometriosis was present after TVS examination. For detection of vaginal endometriosis, the overall pooled sensitivity and specificity were 58% (95%CI, 40-74%) and 96% (95%CI, 87-99%), respectively. The pretest probability of vaginal endometriosis was 17%, which increased to 76% when suspicion of endometriosis was present after TVS assessment. Substantial heterogeneity was found for sensitivity and specificity for all these locations. For detection of bladder endometriosis, the overall pooled sensitivity and specificity were 62% (95%CI, 40-80%) and 100% (95%CI, 97-100%), respectively. Moderate heterogeneity was found for sensitivity and specificity for bladder endometriosis. The pretest probability of bladder endometriosis was 5%, which increased to 92% when suspicion of endometriosis was present after TVS assessment.
CONCLUSION: Overall diagnostic performance of TVS for detecting DIE in uterosacral ligaments, rectovaginal septum, vagina and bladder is fair with high specificity.
Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bladder endometriosis; deep endometriosis; meta-analysis; rectovaginal septum; systematic review; transvaginal ultrasound; uterosacral ligaments; vaginal endometriosis

Mesh:

Year:  2015        PMID: 26250349     DOI: 10.1002/uog.15667

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  23 in total

Review 1.  To operate or not to operate on women with deep infiltrating endometriosis (DIE) before in vitro fertilization (IVF).

Authors:  Márcia Mendonça Carneiro; Luciana Maria Pyramo Costa; Ivete de Ávila
Journal:  JBRA Assist Reprod       Date:  2017-06-01

2.  How long does a transvaginal ultrasound examination for endometriosis take in comparison to a routine transvaginal ultrasound examination?

Authors:  Alison Deslandes; Nayana Parange; Jessie T Childs; Brooke Osborne; Catrina Panuccio; Anthea Croft; Eva Bezak
Journal:  Australas J Ultrasound Med       Date:  2021-12-05

Review 3.  Overall Adiposity, Adipose Tissue Distribution, and Endometriosis: A Systematic Review.

Authors:  Uba Backonja; Germaine M Buck Louis; Diane R Lauver
Journal:  Nurs Res       Date:  2016 Mar-Apr       Impact factor: 2.381

4.  What to choose and why to use - a critical review on the clinical relevance of rASRM, EFI and Enzian classifications of endometriosis.

Authors:  G Hudelist; L Valentin; E Saridogan; G Condous; M Malzoni; H Roman; D Jurkovic; J Keckstein
Journal:  Facts Views Vis Obgyn       Date:  2021-12

5.  The Reproducibility of Ultrasonographic Findings of Rectosigmoid Endometriosis Among Examiners With Different Level of Expertise.

Authors:  Stefano Guerriero; MariaAngela Pascual; Silvia Ajossa; Manuela Neri; Monica Pilloni; Betlem Graupera; Ignacio Rodriguez; Juan Luis Alcazar
Journal:  J Ultrasound Med       Date:  2021-04-10       Impact factor: 2.754

6.  Applying a statistical method in transvaginal ultrasound training: lessons from the learning curve cumulative summation test (LC-CUSUM) for endometriosis mapping.

Authors:  Vered H Eisenberg; Juan L Alcazar; Nissim Arbib; Eyal Schiff; Reuven Achiron; Motti Goldenberg; David Soriano
Journal:  Gynecol Surg       Date:  2017-10-03

Review 7.  Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment.

Authors:  Edgardo Rolla
Journal:  F1000Res       Date:  2019-04-23

8.  Rectal water contrast transvaginal ultrasound versus double-contrast barium enema in the diagnosis of bowel endometriosis.

Authors:  Jipeng Jiang; Ying Liu; Kun Wang; Xixiang Wu; Ying Tang
Journal:  BMJ Open       Date:  2017-09-07       Impact factor: 2.692

9.  European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis.

Authors:  M Bazot; N Bharwani; C Huchon; K Kinkel; T M Cunha; A Guerra; L Manganaro; L Buñesch; A Kido; K Togashi; I Thomassin-Naggara; A G Rockall
Journal:  Eur Radiol       Date:  2016-12-05       Impact factor: 5.315

10.  Neuroendocrine appendiceal tumor and endometriosis of the appendix: a case report.

Authors:  Rogério Serafim Parra; Marley Ribeiro Feitosa; Giovana Bachega Badiale Biagi; Daniel Ferracioli Brandão; Margarida Maria Fernandes da Silva Moraes; Liliane Silvestre; José Vitor Cabral Zanardi; Nelson Hitamo Sato Junior; Omar Féres; José Joaquim Ribeiro da Rocha
Journal:  J Med Case Rep       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.